Margot Robbie’s Gin Faces Rejection Over Shellfish Allergy Warning
London’s hospitality scene is proving a tougher market than anticipated for Papa Salt, the gin brand co-founded by actor Margot Robbie. The spirit, launched in the UK in 2024 and currently stocked in retailers like Harvey Nichols and Waitrose, is facing resistance from bars and restaurants due to an unusual ingredient: oyster shells. The inclusion of oyster shells as a botanical, intended to evoke Robbie’s Australian roots, necessitates a warning on the bottle about potential allergen risks for those with shellfish allergies, creating a compliance headache for venues.
The issue isn’t the flavour profile – spirits expert Greg Dillon, who runs the Great Drams website, notes that oyster shells contribute minimal flavour, primarily acting as a “brand story” element. Rather, it’s the operational burden and potential liability. Bar owners are hesitant to add another allergen inquiry to their service protocol, particularly given the severity of shellfish allergies, which can include anaphylaxis, a potentially fatal reaction. “In order to stock her gin, we would have to train all our staff to ask guests if they have a shellfish allergy when they ordered a G&T,” one bar owner told the Guardian, adding that the time and risk weren’t worth it.
The Allergic Reaction to a Novel Botanical
The core of the problem lies in UK food regulations. Richard Legg, a spirits consultant at Distilled Knowledge, explains that while most spirits are exempt from declaring allergens due to the distillation process, this exemption doesn’t extend to molluscs. Even using just the shells, it’s difficult to guarantee complete removal of allergenic proteins, requiring a mandatory warning label. This contrasts with spirits made from common allergens like cereals, where distillation often eliminates the risk to a negligible level.
Robbie and her husband, Tom Ackerley, have reportedly been personally visiting London venues to encourage them to stock Papa Salt, but have largely been unsuccessful. The reluctance isn’t about the gin’s quality, but about the added complexity and potential risk it introduces. One restaurant manager, speaking to the Guardian, highlighted the current pressures on the hospitality industry, stating they “don’t want to have to ask people if they are allergic to molluscs when they order a gin.”
Reformulation and Market Strategy
Responding to the feedback, Papa Salt has announced a reformulation of the gin, removing the oyster shell botanical. A spokesperson confirmed the change, stating that the decision was made after receiving direct feedback from London restaurateurs. The oyster-free version is expected to be available in the UK by the end of 2026, with the transition already underway in the Australian market. Despite the change, the brand continues to market the gin as featuring “Australian botanicals like wattleseed, wax flower, and oyster shell” – a phrasing that may need to be updated.
This isn’t the first time a celebrity has ventured into the spirits market. George Clooney’s Casamigos tequila was acquired by Diageo for $1 billion in 2017, demonstrating the potential financial rewards. Brad Pitt and Emma Watson have also launched their own gin brands, and Snoop Dogg has a well-established spirits portfolio. Still, Papa Salt’s experience highlights the importance of navigating regulatory hurdles and understanding the operational realities of the hospitality industry.
The Broader Celebrity Spirits Landscape
The celebrity-backed spirits market has seen significant growth in recent years, fueled by brand recognition and marketing power. However, success isn’t guaranteed. Beyond the initial buzz, these brands must compete on quality, price, and distribution. Papa Salt’s initial strategy of leveraging a unique botanical to tell a brand story was appealing, but the unforeseen allergen concerns demonstrate the need for thorough due diligence and a pragmatic approach to market entry. The brand’s current retail presence in Harvey Nichols and Waitrose suggests a positioning towards a premium market segment, but wider adoption hinges on overcoming the concerns of bars and restaurants.
Cost of Compliance vs. Brand Identity
The situation presents a clear trade-off between maintaining a unique brand identity and minimizing operational costs for potential stockists. While the oyster shell botanical contributes to Papa Salt’s narrative, the cost of staff training and the risk of a severe allergic reaction outweigh the perceived benefits for many venues. The reformulation addresses this issue, but it also represents a shift away from the original concept and potentially dilutes the brand’s distinctiveness. The financial impact of the reformulation isn’t publicly available, but it likely includes costs associated with recipe development, production adjustments, and potential marketing updates.
What’s Next for Papa Salt
The immediate focus for Papa Salt is the complete rollout of the oyster-free formulation, first in Australia and then in the UK. The brand will need to manage the transition carefully, ensuring consistent quality and maintaining its premium positioning. Marketing efforts will likely emphasize the gin’s Australian botanicals and smooth flavour profile, downplaying the previous oyster shell component. The company will also need to actively re-engage with London bars and restaurants, demonstrating the revised formulation and addressing any remaining concerns. The success of this strategy will determine whether Papa Salt can achieve Robbie’s original vision of seeing her gin stocked in her local pubs and bars.
Looking ahead, the case of Papa Salt serves as a cautionary tale for other celebrity-backed spirits brands. It underscores the importance of thorough regulatory compliance, understanding the operational needs of the hospitality industry, and prioritizing consumer safety. The brand’s ability to adapt and respond to feedback will be crucial for its long-term success in a competitive market.
Further information on allergen regulations can be found on the Food Standards Agency website.